Rubinstein Samuel
Transaction: 11/18/2025
BUY
Change
+2,168
Price
$1.40
Filing
11/18/2025
Type
BUY
STRATA Skin Sciences, Inc.
SSKN • Medical - Devices
$0.01
— 0.00 (0.00%)
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$29,440.995
Growth
-8.9%
Cash Flow
0/5
Trend
Negative
Evidence
High debt level · 5.59Weak liquidity · 0.58Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 25, 2026, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.01
Change0.00%
Shares Out5.89M
Market Cap$29.44K
Enterprise Value$8.15M
Beta-0.05
P/E-0.00
P/S0.00
P/B0.01
P/FCF-0.01
EV/Sales0.27
EV/EBITDA-14.46
Price$0.01
Change0.00%
Shares Out5.89M
Market Cap$29.44K
Enterprise Value$8.15M
Beta-0.05
P/E-0.00
P/S0.00
P/B0.01
P/FCF-0.01
EV/Sales0.27
EV/EBITDA-14.46
EV/FCF-1.91
Dividend Yield0.00%
Gross Margin58.25%
Oper. Margin-19.01%
Profit Margin-20.40%
Debt/Eq5.59
Current Ratio0.58
Quick Ratio0.48
Revenue 5Y-8.94%
Volume4.88K
Avg Volume11.56K
EPS Surprise0.39
Investment DNA
How strong this company looks for long-term investors
30
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
54/100
Why this score▼
High debt level · 5.59Weak liquidity · 0.58Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Financial Health
Score4 / 20
Debt / Equity: 5.59
Current Ratio: 0.58
Quick Ratio: 0.48
Status: HighRisk
Warnings
- High debt level
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
Rubinstein Samuel
Transaction: 11/17/2025
SELL
Change
-1,394
Price
$1.36
Filing
11/18/2025
Type
SELL
Rafaeli Dolev
Transaction: 05/13/2025
BUY
Change
+58,000
Price
$2.55
Filing
05/15/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rubinstein Samuel | BUY | +2,168 | $1.40 | 11/18/2025 | 11/18/2025 |
| Rubinstein Samuel | SELL | -1,394 | $1.36 | 11/17/2025 | 11/18/2025 |
| Rafaeli Dolev | BUY | +58,000 | $2.55 | 05/13/2025 | 05/15/2025 |
| Gillings John T | BUY | +30,000 | $2.55 | 05/13/2025 | 05/15/2025 |
| Gov Shmuel | BUY | +40,000 | $2.55 | 05/13/2025 | 05/15/2025 |
| Gillings John T | OTHER | 0 | Not reported | 11/13/2024 | 11/14/2024 |
| Allgeier Christina L | BUY | +20,000 | $3.17 | 10/29/2024 | 10/30/2024 |
| Allgeier Christina L | OTHER | 0 | Not reported | 10/29/2024 | 10/29/2024 |
| Rafaeli Dolev | BUY | +19,100 | $3.14 | 07/15/2024 | 07/17/2024 |
| Accelmed Partners, L.P. | BUY | +230,573 | $3.14 | 07/15/2024 | 07/17/2024 |
| Geiger Uri | BUY | +230,573 | $3.14 | 07/15/2024 | 07/17/2024 |
| Gov Shmuel | BUY | +14,338 | $0.44 | 12/01/2023 | 12/05/2023 |
| Lesovitz Christopher | BUY | +337,500 | $0.50 | 11/21/2023 | 11/22/2023 |
| Gov Shmuel | BUY | +416,250 | $0.50 | 11/21/2023 | 11/22/2023 |
| Rubinstein Samuel | SELL | -1,000 | $0.32 | 11/16/2023 | 11/20/2023 |
| Rafaeli Dolev | SELL | 0 | Not reported | 10/30/2023 | 10/30/2023 |
| Rafaeli Dolev | BUY | +1,745,569 | $0.53 | 10/30/2023 | 10/30/2023 |
| Yaniv Irit | BUY | +20,000 | $0.53 | 10/26/2023 | 10/27/2023 |
| Cafran Wayne | BUY | +20,000 | $0.53 | 10/26/2023 | 10/27/2023 |
| Rubinstein Samuel | BUY | +20,000 | $0.53 | 10/26/2023 | 10/27/2023 |